This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Verona Pharma Plc. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Kevin Stephen Turner: Innovator in Pharmaceutical Compositions
Introduction
Kevin Stephen Turner is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on particulate compositions. With a total of 2 patents to his name, Turner continues to push the boundaries of pharmaceutical science.
Latest Patents
Turner's latest patents focus on a particulate composition comprising ensifentrine. The disclosure details a composition that includes from greater than 0.00 wt % to 0.60 wt % of 1,3-bis(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)urea (BMIQU) relative to the total weight of ensifentrine. Additionally, it includes from 0.00 wt % to 0.50 wt % of a biuret impurity of formula (A) relative to the total weight of ensifentrine. The patents also describe liquid pharmaceutical compositions comprising the particulate composition and a process for producing it.
Career Highlights
Kevin Stephen Turner is currently associated with Verona Pharma Plc, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in developing new therapeutic options for patients, showcasing his commitment to improving healthcare outcomes.
Collaborations
Turner collaborates with various professionals in the field, including his coworker Peter Lionel Spargo. Their combined efforts contribute to the advancement of pharmaceutical research and development.
Conclusion
Kevin Stephen Turner is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. His innovative patents and collaborations reflect his dedication to advancing medical science.